Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Transcutaneous auricular vagus nerve stimulation for people with disorders of consciousness

Official title: Effects of Pairing Transcutaneous Auricular Vagus Nerve Stimulation on Patients With Disorders of Consciousness: An Exploratory Single-Center Randomized Controlled Trial

Run by Zhujiang Hospital · NCT07284732 · Data updated 2026-11-12

This test tries transcutaneous auricular vagus nerve stimulation (taVNS) to see if it helps adults who are in a vegetative state or a minimally conscious state.

More Disorders of Consciousness trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment20 (estimated)
SponsorZhujiang Hospital
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedMay 1, 2024
Main results expectedMay 1, 2026
Study endsMay 31, 2027
Registry record updatedMarch 31, 2026
Trial IDNCT07284732 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–70 years old with a diagnosis of VS or MCS by CRS-R, between 28 days and one year after severe brain injury, medically stable, and without implants or medications that would interfere with stimulation.

Probably not a fit

Patients with uncontrolled epilepsy, seizures in the past four weeks, cranial metal implants or pacemakers, recent craniotomy at the stimulation site, or on interfering medications are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional protocol applies noninvasive transcutaneous auricular vagus nerve stimulation (taVNS) to patients with disorders of consciousness after severe brain injury. It enrolls adults aged 18–70 whose condition has lasted more than 28 days but less than one year and who are diagnosed as vegetative state (VS) or minimally conscious state (MCS) by the Coma Recovery Scale–Revised (CRS-R). Key exclusions include recent seizures, pacemakers or cranial metal implants, concurrent neuromodulation trials, and medications that interfere with cerebral stimulation; skin at the auricular site must be intact. Participants receive taVNS while clinicians monitor behavioral responses with CRS-R and record brain activity with EEG at the single center in Guangzhou.

Why it matters

Potential benefit: If successful, taVNS could improve levels of consciousness and functional recovery for some patients with disorders of consciousness.

How similar studies have gone: Small case reports and early small trials of invasive and noninvasive vagus nerve stimulation in disorders of consciousness have reported mixed but sometimes promising signals, though larger controlled trials remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18-70 years, with a disease duration exceeding 28 days but not longer than 1 year.
* Patients diagnosed with disorders of consciousness (DoC), specifically classified as either vegetative state (VS) or minimally conscious state (MCS) according to the Coma Recovery Scale-Revised (CRS-R) based on international guidelines.
* No prior history of neuropsychiatric disorders.
* Absence of contraindications to transcutaneous auricular vagus nerve stimulation (taVNS) or electroencephalography (EEG), and no concurrent use of sedatives or medications that may interfere with cerebral stimulation-including Na⁺ or Ca²⁺ channel blockers or NMDA receptor antagonists.
* Intact skin at the auricular site.

Exclusion Criteria:

* Participation in other trials involving non-invasive or invasive neuromodulation.
* Uncontrolled epilepsy, defined as seizures occurring within 4 weeks prior to enrollment.
* Presence of cranial metal implants, pacemakers, craniotomy at the stimulation site, implanted brain devices, or similar conditions.
* Cardiac arrhythmia or other significant cardiovascular abnormalities;
* History of respiratory disorders, including dyspnea, asthma, or hyperventilation.
* History of vasovagal syncope.

Where it's running

  • Zhujiang Hospital of Southern Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.